Barrett & Company’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.6K Hold
115
﹤0.01% 444
2025
Q4
$14.5K Hold
115
﹤0.01% 440
2025
Q3
$16.8K Hold
115
0.01% 427
2025
Q2
$17.9K Hold
115
0.01% 428
2025
Q1
$18.9K Hold
115
0.01% 381
2024
Q4
$18.7K Buy
115
+15
+15% +$2.68K 0.01% 378
2024
Q3
$19.5K Sell
100
-161
-62% -$29.7K 0.01% 366
2024
Q2
$45.2K Buy
261
+1
+0.4% +$166 0.02% 271
2024
Q1
$44.1K Hold
260
0.02% 290
2023
Q4
$51.4K Hold
260
0.03% 254
2023
Q3
$45.3K Hold
260
0.03% 254
2023
Q2
$44.8K Buy
260
+9
+4% +$1.56K 0.03% 259
2023
Q1
$41.8K Buy
251
+15
+6% +$2.46K 0.03% 258
2022
Q4
$34.6K Hold
236
0.02% 260
2022
Q3
$34.6K Buy
+236
New +$39.4K 0.02% 260

Other funds holding ZTS

Barrett & Company's ZTS Position: Q1 2026 in Review

Barrett & Company held its Zoetis (ZTS) position steady in Q1 2026 at 115 shares worth $13.6K. The position accounts for ﹤0.01% of the portfolio, ranked #444.

Barrett & Company first reported a position in ZTS in Q3 2022 and has held it in 15 quarters since. The position peaked at $51.4K in Q4 2023. 1,605 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • Barrett & Company held 115 shares of Zoetis worth $13.6K as of Q1 2026.
  • Barrett & Company left its Zoetis share count unchanged in Q1 2026.
  • Zoetis made up ﹤0.01% of Barrett & Company's portfolio in Q1 2026, its #444 holding.
  • Barrett & Company first reported a position in Zoetis in Q3 2022 and has held it in 15 quarters since.
  • Barrett & Company's Zoetis position peaked at $51.4K in Q4 2023.
  • 1,605 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Barrett & Company's 13F filing for Q1 2026, filed 4 May 2026.